… pneumonitis, or whether development of PTM is affected by disease-modifying drugs
such as dexamethasone (standard of care for our cohort) or different variants of SARS-CoV-2. …

… Combined evidence suggests that dexamethasone should be considered … with Covid-19
pneumonitis requiring supplemental oxygen therapy or ventilatory support. Dexamethasone is …

… (PO) dexamethasone 6 mg daily during the admission as per the local treatment protocol
for COVID-19 pneumonitis. The recommended administration time for dexamethasone was in …

… to ICU with confirmed COVID-19 Pneumonitis, older than 18 … of dexamethasone for the
treatment of severe COVID-19 (pre-… in the management of COVID-19 pneumonitis ( 11–13 ). In …

… of breath, progressive pneumonitis, severe complications and … hospitalized with Covid-19,
the use of dexamethasone resulted … type or common type of COVID-19 pneumonia. However, …

… Clinical presentation ranges from mild to severe pneumonitis complicated by respiratory …
A low-middle dose of dexamethasone and heparin seems to be effective in COVID-19 patients, …

… September 2020 showed a complete metabolic response and the absence of pneumonitis.
… of COVID-19 was nonetheless initially retained and the patient received dexamethasone …

… 1B, 2B), and systemic corticosteroids were … of corticosteroids. A drug lymphocyte stimulation
test performed using peripheral lymphocytes showed a negative reaction to the COVID-19 …

… , colitis, hepatitis, endocrinopathies, and pneumonitis. The treatment of irAEs requires …
Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone …

… pneumonitis which is treated with discontinuation of amiodarone and initiation of corticosteroids.
… During the COVID-19 era, the incidence of delay in treatment of pulmonary pathology is …